Leukemia Clinical Trials in New York

Showing 1481-1500 of 1,787 trials

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

NCT00994123

A Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).

Merrimack Pharmaceuticals162 participantsStarted Feb 2010

Birmingham, Alabama, United States • Tucson, Arizona, United States • Loma Linda, California, United States +35 more locations

COMPLETEDPhase 1/2< 1 mile

Back on My Feet: Emotional Recovery From Fall Injury

NCT01998945

We will compare two programs that are designed to help older adults who have had fall injuries manage anxiety and improve their level of functioning. We expect that both programs will provide some benefit, but that one will promote better management.

Posttraumatic Stress DisorderSubsyndromal Posttraumatic Stress DisorderFear of Falling

Weill Medical College of Cornell University22 participantsStarted Dec 2013

New York, New York, United States

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Back on My Feet: Emotional Recovery From Fall Injury

Leukemia Trials in Other Cities

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Metronomic Chemotherapy in Advanced Gastric Cancer

Other Conditions in New York